Literature DB >> 11943652

Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells.

Timothy P Quinn1, Marielle Schlueter, Scott J Soifer, Jorge A Gutierrez.   

Abstract

Vascular endothelial growth factor (VEGF) and basic (b) fibroblast growth factor (FGF-2/bFGF) are involved in vascular development and angiogenesis. Pulmonary artery smooth muscle cells express VEGF and FGF-2 and are subjected to mechanical forces during pulsatile blood flow. The effect of stretch on growth factor expression in these cells is not well characterized. We investigated the effect of cyclic stretch on the expression of VEGF and FGF-2 in ovine pulmonary artery smooth muscle cells. Primary confluent cells from 6-wk-old lambs were cultured on flexible silicon membranes and subjected to cyclic biaxial stretch (1 Hz; 5-25% stretch; 4-48 h). Nonstretched cells served as controls. Expression of VEGF and FGF-2 was determined by Northern blot analysis. Cyclic stretch induced expression of both VEGF and FGF-2 mRNA in a time- and amplitude-dependent manner. Maximum expression was found at 24 h and 15% stretch (VEGF: 1.8-fold; FGF-2: 1.9-fold). These results demonstrate that mechanical stretch regulates VEGF and FGF-2 gene expression, which could play a role in pulmonary vascular development or in postnatal pulmonary artery function or disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943652     DOI: 10.1152/ajplung.00044.2001

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  27 in total

Review 1.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

2.  Role of different negative pressure values in the process of infected wounds treated by vacuum-assisted closure: an experimental study.

Authors:  Min Zhou; Aixi Yu; Gang Wu; Chengyan Xia; Xiang Hu; Baiwen Qi
Journal:  Int Wound J       Date:  2012-05-29       Impact factor: 3.315

3.  l-Citrulline treatment alters the structure of the pulmonary circulation in hypoxic newborn pigs.

Authors:  Eric B McClellan; Zhengming Wang; Kurt H Albertine; Mark R Kaplowitz; Yongmei Zhang; Candice D Fike
Journal:  Pediatr Pulmonol       Date:  2020-07-24

Review 4.  Can We Understand the Pathobiology of Bronchopulmonary Dysplasia?

Authors:  Cristina M Alvira; Rory E Morty
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

5.  Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress.

Authors:  Joanna Costa; Yan Zhu; Timothy Cox; Paul Fawcett; Thomas Shaffer; Deepthi Alapati
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  Role of shear-stress-induced VEGF expression in endothelial cell survival.

Authors:  Nathaniel G dela Paz; Tony E Walshe; Lyndsay L Leach; Magali Saint-Geniez; Patricia A D'Amore
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

Review 7.  The tension mounts: mechanics meets morphogenesis and malignancy.

Authors:  Matthew J Paszek; Valerie M Weaver
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-10       Impact factor: 2.673

8.  Cyclic stretch stimulates mitochondrial reactive oxygen species and Nox4 signaling in pulmonary artery smooth muscle cells.

Authors:  Stephen Wedgwood; Satyan Lakshminrusimha; Paul T Schumacker; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-29       Impact factor: 5.464

9.  Wound contraction and macro-deformation during negative pressure therapy of sternotomy wounds.

Authors:  Christian Torbrand; Martin Ugander; Henrik Engblom; Håkan Arheden; Richard Ingemansson; Malin Malmsjö
Journal:  J Cardiothorac Surg       Date:  2010-09-30       Impact factor: 1.637

Review 10.  Immune and inflammatory mechanisms in pulmonary arterial hypertension.

Authors:  Hala El Chami; Paul M Hassoun
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.